General Information of Disease (ID: DISK4XHT)

Disease Name Neoplasm of testis
Synonyms
testis tumor; tumour of testis; testicular tumour; testis tumour; tumor of the testis; tumour of the testis; testis neoplasm; neoplasm of the testis; testicular neoplasm; neoplasm of testis; testis neoplasm (disease); tumor of testis; testicular tumor
Definition A neoplasm (disease) that involves the testis.
Disease Hierarchy
DISTBY9Z: Tumour
DISJZN92: Male reproductive system neoplasm
:
DISK4XHT: Neoplasm of testis
Disease Identifiers
MONDO ID
MONDO_0021348
MESH ID
D013736
UMLS CUI
C0039590
MedGen ID
52675
HPO ID
HP:0010788
SNOMED CT ID
126900000

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 13 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
BAP1 TT47RXJ moderate Biomarker [1]
BAK1 TTFM7V0 Strong Genetic Variation [2]
CENPE TTZD5QR Strong Genetic Variation [3]
CGB3 TTUH273 Strong Biomarker [4]
HPGDS TTCYE56 Strong Genetic Variation [5]
KITLG TTDJ51N Strong Genetic Variation [3]
KLK14 TTDA81R Strong Altered Expression [6]
LCT TTA0OSE Strong Biomarker [7]
MAD1L1 TTNE9U7 Strong Genetic Variation [5]
MAPK8IP1 TTXKZ8Q Strong Altered Expression [8]
MLANA TT362RB Strong Biomarker [9]
PDE11A TTTWC79 Strong Biomarker [10]
TDGF1 TTN7HMG Strong Biomarker [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 DTT(s)
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
UCK2 DETN1O0 Strong Genetic Variation [3]
------------------------------------------------------------------------------------
This Disease Is Related to 24 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
SERINC1 OTF3UASX Limited Biomarker [12]
SERINC2 OTZ039U0 Limited Biomarker [12]
SERINC3 OTQ1LAJ1 Limited Altered Expression [12]
STK11 OT1YZSP3 Limited Posttranslational Modification [13]
ASCC3 OTF6DCYB Strong Biomarker [14]
ATF7IP OTU6ZA7F Strong Genetic Variation [3]
CCDC54 OTW5WCX9 Strong Biomarker [15]
DDX1 OT3U8FD0 Strong Biomarker [14]
DDX56 OTGURA53 Strong Biomarker [14]
DMRT1 OT5PU9U1 Strong Genetic Variation [3]
ENTPD5 OTFH05B9 Strong Biomarker [16]
ERCC1 OTNPYQHI Strong Biomarker [17]
ERCC4 OTFIOPG1 Strong Biomarker [17]
FXYD5 OT81DIOD Strong Altered Expression [18]
GTF2H2 OTK72L9I Strong Altered Expression [19]
IFI44 OTOKSZVA Strong Altered Expression [19]
INHA OT7HWCO3 Strong Biomarker [20]
KLK13 OT8LOD2U Strong Altered Expression [21]
MCM3AP OT895FEC Strong Genetic Variation [3]
PATZ1 OT0X9WGR Strong Biomarker [22]
PITX1 OTA0UN4C Strong Genetic Variation [3]
PRDM14 OTWZKY4L Strong Genetic Variation [3]
RFWD3 OTDUULBQ Strong Genetic Variation [5]
SLC25A44 OTHHPC3C Strong Genetic Variation [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 24 DOT(s)

References

1 Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.Genes Chromosomes Cancer. 2015 Jan;54(1):51-62. doi: 10.1002/gcc.22218. Epub 2014 Sep 18.
2 Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group.Genes Chromosomes Cancer. 2017 Jul;56(7):548-558. doi: 10.1002/gcc.22457. Epub 2017 Apr 4.
3 Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.Nat Genet. 2013 Jun;45(6):686-9. doi: 10.1038/ng.2635. Epub 2013 May 12.
4 Low-grade Endometrioid Stromal Sarcoma of the Paratestis: A Novel Report With Molecular Confirmation of JAZF1/SUZ12 Translocation.Am J Surg Pathol. 2018 May;42(5):695-700. doi: 10.1097/PAS.0000000000001030.
5 Meta-analysis identifies four new loci associated with testicular germ cell tumor.Nat Genet. 2013 Jun;45(6):680-5. doi: 10.1038/ng.2634. Epub 2013 May 12.
6 Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.Br J Cancer. 2002 Nov 18;87(11):1287-93. doi: 10.1038/sj.bjc.6600623.
7 Characteristics of Patients With Sertoli and Leydig Cell Testis Neoplasms From a National Population-Based Registry.Clin Genitourin Cancer. 2017 Apr;15(2):e263-e266. doi: 10.1016/j.clgc.2016.08.001. Epub 2016 Aug 12.
8 The JNK interacting protein JIP-1 and insulin like growth factor II genes are co-expressed in human embryonic tumours.Anticancer Res. 2005 Mar-Apr;25(2A):1075-8.
9 Autopsy and genetic diagnosis of 21-hydroxylase deficiency with bilateral testicular tumors in a case under no medication for over one year.Forensic Sci Int. 2011 Mar 20;206(1-3):e71-5. doi: 10.1016/j.forsciint.2010.09.017. Epub 2010 Oct 15.
10 Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.J Clin Endocrinol Metab. 2011 Jan;96(1):E208-14. doi: 10.1210/jc.2010-1704. Epub 2010 Nov 3.
11 Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.Oncogene. 1997 Aug 18;15(8):927-36. doi: 10.1038/sj.onc.1201260.
12 Identification of TDE2 gene and its expression in non-small cell lung cancer.Int J Cancer. 2003 Nov 1;107(2):238-43. doi: 10.1002/ijc.11391.
13 Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome.Oncogene. 2000 Jan 6;19(1):164-8. doi: 10.1038/sj.onc.1203227.
14 DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene.Cancer Sci. 2018 Aug;109(8):2479-2489. doi: 10.1111/cas.13661. Epub 2018 Jul 17.
15 Cancer immunotherapy targeting Sp17: when should the laboratory findings be translated to the clinics?.Am J Hematol. 2005 Sep;80(1):6-11. doi: 10.1002/ajh.20415.
16 PCPH expression is an early event in the development of testicular germ cell tumors.Int J Oncol. 2006 Mar;28(3):595-604.
17 ERCC1 and XPF expression in human testicular germ cell tumors.Oncol Rep. 2010 Jan;23(1):223-7.
18 Involvement of dysadherin and E-cadherin in the development of testicular tumours.Br J Cancer. 2005 Dec 12;93(12):1382-7. doi: 10.1038/sj.bjc.6602880.
19 The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors.J Urol. 2007 May;177(5):1918-22. doi: 10.1016/j.juro.2007.01.017.
20 Inhibin-, E-cadherin, calretinin and Ki-67 antigen in the immunohistochemical evaluation of canine and human testicular neoplasms.Folia Histochem Cytobiol. 2014;52(4):326-34. doi: 10.5603/FHC.a2014.0036. Epub 2014 Dec 16.
21 Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer.Anticancer Res. 2001 Sep-Oct;21(5):3147-52.
22 PATZ1 gene has a critical role in the spermatogenesis and testicular tumours.J Pathol. 2008 May;215(1):39-47. doi: 10.1002/path.2323.